Regulation · EU
Commission Regulation (EU) 2021/2202 of 9 December 2021 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, Bacillus subtilis strain IAB/BS03, emamectin, flutolanil and imazamox in or on certain products (Text with EEA relevance)
- Identifier
- CELEX 32021R2202
- Status
- in_force
- Adopted
- 9 December 2021
- Published
- 9 December 2021
- Language
- en
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R2202
- Source provider
- eurlex
- Retrieved
- 2026-08-27T21:43:16.426Z
Identifier
- CELEX: 32021R2202 · eurlex
Direct relationships
PoliticalRepo: CELEX 32021R2202
- Identifier matchPROJECTS_FROM
Same CELEX 32021R2202 projected from PoliticalRepo EUR-Lex row 32021R2202.
LegalInstrument → PoliticalRecord · Open related record